Security key
426897104
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)
CUSIP: 426897104
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 29,123,952
- Total 13F shares
- 7,146,392
- Share change
- -368,744
- Total reported value
- $3,611,286
- Put/Call ratio
- 12%
- Price per share
- $0.51
- Number of holders
- 25
- Value change
- -$218,778
- Number of buys
- 9
- Number of sells
- 11
Report period
Q3 2022
Institutions
25
Top holders
10
HEPA full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Hepion Pharmaceuticals, Inc. SEC filings
Hepion Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 426897104
Recent filing periods:
Top shareholders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
3,308,523
|
$1,894,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.5%
|
1,614,716
|
$924,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
658,110
|
$376,000 | — | 30 Jun 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.4%
|
410,189
|
$235,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
313,500
|
$179,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.81%
|
234,600
|
$134,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.54%
|
158,214
|
$91,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
133,264
|
$77,000 | — | 30 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.32%
|
93,769
|
$54,000 | — | 30 Jun 2022 | |
| McAdam, LLC |
13F
|
Company |
0.21%
|
62,169
|
$36,000 | — | 30 Jun 2022 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.21%
|
60,054
|
$34,000 | — | 30 Jun 2022 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.2%
|
57,534
|
$33,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.16%
|
45,800
|
$26,000 | — | 30 Jun 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
45,108
|
$26,000 | — | 30 Jun 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.14%
|
40,445
|
$23,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
31,535
|
$19,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
25,638
|
$15,000 | — | 30 Jun 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.09%
|
25,536
|
$15,000 | — | 30 Jun 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.09%
|
24,764
|
$14,000 | — | 30 Jun 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.08%
|
22,935
|
$13,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.04%
|
11,648
|
$7,000 | — | 30 Jun 2022 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
10,090
|
$5,000 | — | 30 Jun 2022 | |
| Amplius Wealth Advisors, LLC |
13F
|
Company |
0.03%
|
10,000
|
$5,000 | — | 30 Jun 2022 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0.02%
|
5,000
|
$2,000 | — | 30 Jun 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
3,500
|
$2,005 | — | 30 Jun 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
1,770
|
$1,000 | — | 30 Jun 2022 | |
| BENJAMIN F. EDWARDS & COMPANY, INC. |
13F
|
Company |
0%
|
1,001
|
$1,000 | — | 30 Jun 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
1
|
$1,000 | — | 30 Jun 2022 | |
| Cavan John T. |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
1,581,060
|
— | — | 18 May 2021 | |
| Arnold Lippa |
3/4/5
|
Director |
—
class O/S missing
|
291,110
|
— | — | 18 May 2021 | |
| Thomas Adams PhD |
3/4/5
|
Director |
—
class O/S missing
|
291,050
|
— | — | 18 May 2021 |
Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q3 2022
As of 30 Sep 2022,
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,146,392 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Bank of New York Mellon Corp, NORTHERN TRUST CORP, PVG ASSET MANAGEMENT CORP, and ENVESTNET ASSET MANAGEMENT INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
26
Q3 2022 holders
25
Holder diff
-1
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.